Sale!

LGMD NGS Panel

Original price was: $626.Current price is: $500.

-20%

The LGMD NGS Panel is a comprehensive genetic test that utilizes next-generation sequencing technology to identify mutations associated with limb-girdle muscular dystrophy. This advanced diagnostic tool analyzes multiple genes simultaneously, providing a thorough assessment of genetic factors contributing to muscle weakness and wasting conditions. The test is particularly valuable for individuals experiencing progressive muscle weakness in the hips and shoulders, difficulty walking, frequent falls, or family history of muscular disorders. By identifying specific genetic mutations, the LGMD NGS Panel enables accurate diagnosis, informs treatment strategies, and provides crucial information for family planning. The test is available for $500 USD, offering significant savings from the regular price of $626 USD.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

LGMD NGS Panel: Comprehensive Genetic Testing for Limb-Girdle Muscular Dystrophy

Understanding the LGMD NGS Panel

The LGMD NGS Panel represents a breakthrough in genetic diagnostics for neuromuscular disorders. This comprehensive test utilizes cutting-edge next-generation sequencing (NGS) technology to analyze multiple genes associated with limb-girdle muscular dystrophy (LGMD) in a single, efficient analysis. LGMD encompasses a group of genetic disorders characterized by progressive weakness and wasting of muscles, primarily affecting the shoulder and pelvic girdles.

Traditional genetic testing methods often required sequential analysis of individual genes, which could be time-consuming and costly. The LGMD NGS Panel revolutionizes this approach by simultaneously examining numerous genes known to cause various forms of limb-girdle muscular dystrophy, providing a comprehensive genetic profile in a single test.

What the LGMD NGS Panel Detects

This advanced genetic panel specifically targets and analyzes:

  • Multiple genes associated with autosomal dominant and recessive forms of LGMD
  • Genetic mutations responsible for progressive muscle weakness
  • Variants affecting muscle protein structure and function
  • Pathogenic changes in sarcoglycan, dysferlin, calpain, and other critical muscle proteins
  • Both known and novel genetic variants through comprehensive sequencing

Comprehensive Gene Coverage

The LGMD NGS Panel provides extensive coverage of genes implicated in various subtypes of limb-girdle muscular dystrophy, ensuring thorough analysis of potential genetic causes for muscular symptoms.

Who Should Consider the LGMD NGS Panel?

This genetic test is particularly recommended for individuals experiencing:

  • Progressive muscle weakness in hips and shoulders
  • Difficulty rising from chairs or climbing stairs
  • Frequent falls or balance problems
  • Muscle wasting in pelvic and shoulder girdles
  • Elevated creatine kinase (CK) levels
  • Family history of muscular dystrophy or unexplained muscle weakness
  • Children or adults with delayed motor milestones
  • Individuals with suspected hereditary myopathy

Early Detection Benefits

Early genetic testing can provide crucial information for managing symptoms, planning appropriate interventions, and understanding disease progression.

Benefits of Taking the LGMD NGS Panel

Choosing the LGMD NGS Panel offers numerous advantages:

  • Accurate Diagnosis: Provides definitive genetic confirmation of LGMD subtype
  • Comprehensive Analysis: Tests multiple genes simultaneously for efficiency
  • Personalized Treatment: Informs targeted therapeutic approaches
  • Family Planning: Provides crucial information for genetic counseling
  • Prognostic Information: Helps predict disease progression and severity
  • Research Contribution: Advances understanding of neuromuscular disorders

Understanding Your Test Results

Your LGMD NGS Panel results will be carefully interpreted by our team of genetic specialists:

Positive Results

A positive result indicates the identification of pathogenic mutations associated with limb-girdle muscular dystrophy. Our genetic counselors will explain:

  • Specific genetic variants detected
  • Associated LGMD subtype and expected clinical features
  • Inheritance pattern and family implications
  • Recommended management strategies
  • Available treatment options and clinical trials

Negative Results

A negative result means no known pathogenic variants were identified in the genes analyzed. This information can help:

  • Rule out common genetic causes of muscle weakness
  • Guide further diagnostic evaluation
  • Provide reassurance when appropriate

Variant of Uncertain Significance (VUS)

Sometimes, genetic changes of unknown clinical significance are identified. Our team will:

  • Explain the uncertainty and its implications
  • Discuss ongoing research and potential reclassification
  • Provide guidance for family member testing when appropriate

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $626

Nationwide Availability

We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services regardless of your location.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about muscle weakness symptoms delay your path to diagnosis and appropriate care. The LGMD NGS Panel provides the comprehensive genetic information needed to understand your condition and plan for the future.

Ready to schedule your LGMD NGS Panel? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Our team is available to answer your questions and guide you through the testing process.

Take control of your genetic health with the advanced diagnostic capabilities of the LGMD NGS Panel. Early and accurate genetic testing can make a significant difference in managing neuromuscular conditions effectively.